Advertisement
Anesthesiology and Pulmonary Medicine
Subscribe to Anesthesiology and Pulmonary Medicine
View Sample

FREE Email Newsletter

Vapotherm Announces Approval in Canada for New High Flow Device Designed for Heliox

July 13, 2011 11:33 am | by Bio-Medicine.Org | News | Comments

STEVENSVILLE, Md., July 13, 2011 /PRNewswire-USNewswire/ -- Vapotherm, a privately held manufacturer of respiratory care devices for hospital and home use, announced today that it has received approval from the Medical Device Bureau of Health Canada for the Precision Flow® Heliox...

Kimberly-Clark Launches KimVent Multi-Access Port Closed Suction System

July 13, 2011 10:33 am | by Bio-Medicine.Org | News | Comments

ROSWELL, Ga., July 13, 2011 /- Marking a significant advance in the fight against Ventilator-associated Pneumonia (VAP), Kimberly-Clark Health Care today announced its launch of KimVent Multi-Access Port (MAP) Closed Suction Systems. The new system features a compact rotating manifold...

Lilly Donation to Patient Advocate Foundation Expands Services and Access for Patients With Most Common Form of Lung Cancer

July 13, 2011 7:36 am | by Bio-Medicine.Org | News | Comments

INDIANAPOLIS, July 13, 2011 /- Eli Lilly and Company (NYSE: LLY ) announced that it has made a charitable contribution to the Patient Advocate Foundation (PAF). The donation will enable expansion of the foundation's patient services programs, including Case Management and Co-Pay Relief...

Advertisement

MetroSouth Surgeon Pioneers Hybrid Treatment of Large Hiatal Hernias and Reflux

July 13, 2011 7:35 am | by Bio-Medicine.Org | News | Comments

BLUE ISLAND, Ill., July 13, 2011 /- Chronic reflux patients who also suffer from large hiatal hernias can now get relief in just one visit to the operating room. MetroSouth Medical Center general surgeon Felipe Gracias, MD, Palos Park, is the first physician in Illinois to treat both...

Kessler is the First Rehabilitation Center in the Nation to Use New Robotic Gait Training System

July 13, 2011 7:35 am | by Bio-Medicine.Org | News | Comments

WEST ORANGE, N.J., July 13, 2011 /- Kessler Foundation ( www.kesslerfoundation.org ) and Kessler Institute for Rehabilitation ( www.kessler-rehab.com ) are the first rehabilitation centers in the U.S. to implement the new LokomatPro V6, an advanced robotic training system designed to...

HASCO Medical Inc. Names Mike Dumais the Vice President of Sales for Southern Medical and Mobility

July 11, 2011 7:33 am | by Bio-Medicine.Org | News | Comments

MOBILE, Ala., July 11, 2011 /- HASCO Medical, Inc. (OTCBB: HASC), www.mysouthernmed.com , a managed healthcare provider that serves patients in Alabama, Florida, and Mississippi, announced today that Mike Dumais has been named Vice President of Sales for Southern Medical and Mobility, a...

GlaxoSmithKline Receives FDA Approval for BOOSTRIX® to Help Prevent Whooping Cough in Adults 65 Years and Older

July 8, 2011 9:33 pm | by Bio-Medicine.Org | News | Comments

NEW YORK, July 8, 2011 /- The U.S. Food and Drug Administration (FDA) has approved BOOSTRIX® [Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine, Adsorbed (Tdap)] for use in adults 65 years of age and older for active booster immunization against tetanus,...

FDA Approves Boostrix to Prevent Tetanus, Diphtheria, and Pertussis in Older People

July 8, 2011 5:35 pm | by Bio-Medicine.Org | News | Comments

SILVER SPRING, Md., July 8, 2011 /PRNewswire-USNewswire/ --The U.S. Food and Drug Administration today approved Boostrix vaccine to prevent tetanus, diphtheria, and pertussis (whooping cough) in people ages 65 and older. (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO )...

Advertisement

Significant Rise in Survival Rates for Elderly Lung Cancer Patients Treated Using Radiosurgery in Netherlands Detailed at World Conference for Lung Cancer

July 6, 2011 7:32 am | by Bio-Medicine.Org | News | Comments

AMSTERDAM, July 6, 2011 /- Details of advances in the use of stereotactic body radiotherapy (SBRT) to treat early stage lung cancer in both high risk operable and inoperable cases were presented at the biennial World Conference for Lung Cancer (WCLC) here in Amsterdam today, including...

ResMed Announces Acquisition of BiancaMed

July 6, 2011 5:32 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO, July 6, 2011 /- ResMed Inc. (NYSE: RMD and ASX: RMD), a leading developer, manufacturer and distributor of medical equipment for treating, diagnosing and managing sleep-disordered breathing and other respiratory disorders, announced today that it has acquired BiancaMed Ltd., a...

First Reportable Data of EarlyCDTâ„¢-Lung Use in Clinical Practice Presented at IASLC World Conference on Lung Cancer

July 5, 2011 6:31 am | by Bio-Medicine.Org | News | Comments

AMSTERDAM, July 5, 2011 /- Oncimmune ® LLC, maker of EarlyCDT™-Lung , a simple blood test that aids physicians in the risk assessment and early detection of lung cancer , today announces that an abstract (P4.013) " EarlyCDT-Lung test: audit of 1,000 patients in clinical...

VisionGate to Present at IASLC Meeting Showing How Adjunctive Use of Its 3D Cell Imaging Platform Can Increase Utility of CT Screening for Lung Cancer

July 3, 2011 10:32 pm | by Bio-Medicine.Org | News | Comments

AMSTERDAM and PHOENIX, July 4, 2011 /- VisionGate, Inc., a company developing a revolutionary non-invasive test for the early detection of lung cancer, today announced that it will present data showing how adjunctive use of its LuCED™ test can improve the utility of low dose x-ray...

FDA Approves XARELTO® (rivaroxaban tablets) to Help Prevent Deep Vein Thrombosis in Patients Undergoing Knee or Hip Replacement Surgery

July 1, 2011 11:32 am | by Bio-Medicine.Org | News | Comments

RARITAN, N.J., July 1, 2011 /- Janssen Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved XARELTO® (rivaroxaban tablets), a novel, once-daily, oral anticoagulant for the prevention (prophylaxis) of deep vein thrombosis (DVT) which may...

Advertisement

Fast Track Total Hip Replacement Surgery Is Effective and Safe

July 1, 2011 9:33 am | by Bio-Medicine.Org | News | Comments

NEW YORK, July 1, 2011 /- Generally healthy patients who undergo total hip replacement (THR) can be fast tracked to be discharged in two days compared with the standard three to six days, according to a new study by researchers at Hospital for Special Surgery (HSS) in New York City. The...

Ataluren Phase 2 Data in Nonsense Mutation Cystic Fibrosis Published in the European Respiratory Journal

July 1, 2011 5:33 am | by Bio-Medicine.Org | News | Comments

SOUTH PLAINFIELD, N.J., July 1, 2011 /- PTC Therapeutics, Inc. (PTC) today announced the publication of data from a Phase 2 study of ataluren, an investigational new drug, in adults with nonsense mutation cystic fibrosis (nmCF) in the European Respiratory Journal . The published...

Phase III Study Shows Once-Daily NVA237 is Superior to Placebo and Similar to Tiotropium in Improving Lung Function in COPD

June 30, 2011 2:33 am | by Bio-Medicine.Org | News | Comments

TOKYO, June 30, 2011 /- GLOW2 Study Shows NVA237 Provides Superior24-hour Bronchodilation to Placebo (p < 0.001) with Comparable Efficacy to Open-Label Tiotropium at 12 Weeks NVA237 Shown to be Well-Tolerated in Patients with Moderate-to-Severe Chronic Obstructive Pulmonary Disease...

Video Features World's First Essential Tremor Patient Treated With Noninvasive MR-Guided Focused Ultrasound

June 29, 2011 6:33 am | by Bio-Medicine.Org | News | Comments

CHARLOTTESVILLE, Va., June 29, 2011 /PRNewswire-USNewswire/ -- The last ten years have been challenging for Billy R. Williams of Fort Valley, Virginia. The former Pentagon employee, who survived the 9/11 terrorist attack, has suffered from essential tremor, a progressive and debilitating...

CardioFocus HeartLightâ„¢ Endoscopic Ablation System Enables Treatment of Atrial Fibrillation: Live Case and Abstract Presented at EHRA EUROPACE 2011

June 29, 2011 3:32 am | by Bio-Medicine.Org | News | Comments

MARLBOROUGH, Mass., June 29, 2011 /- CardioFocus, Inc., developer of the HeartLight™ Endoscopic Ablation System (EAS) for the treatment of atrial fibrillation (AF), announced today  that its technology was featured in a live case and scientific abstract presented at the...

Aeris Therapeutics names new CFO Carter

June 28, 2011 10:34 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Aeris Therapeutics LLC, a Woburn-based drug developer focused on treatments for emphysema and other advanced lung diseases, has appointed a new chief financial officer in Charles R. Carter.

Stanmore Receives US FDA Approval for its JTS Non-invasive Extendible Implant

June 24, 2011 7:33 am | by Bio-Medicine.Org | News | Comments

LONDON, June 24, 2011 /-   Stanmore Implants ("Stanmore"), specialists in the design and manufacture of patient specific implants for complex orthopaedic reconstructions, announces that it has received US FDA 510k approval for its Juvenile Tumour System ("JTS") non-invasive...

Sirnaomics Seals a Second Partnership Deal with a Chinese Pharmaceutical Company for Developing siRNA Therapeutics

June 23, 2011 6:42 am | by Bio-Medicine.Org | News | Comments

GAITHERSBURG, Md., June 23, 2011 /- Sirnaomics, Inc. ( www.sirnaomics.com ) announced today that the company has signed a partnership agreement with Guangdong Zhongsheng Pharmaceutical Co. Ltd., a Chinese pharmaceutical company trading on the Shenzhen Stock Exchange (SZSE: 002317). The...

AT & T to Wirelessly Connect Zephyr BioHarness

June 23, 2011 6:42 am | by Bio-Medicine.Org | News | Comments

DALLAS, June 23, 2011 /- AT&T * and Zephyr Technology today announced an agreement for AT&T to provide integrated wireless access to the next generation of the Zephyr BioHarness™ designed to measure critical vital signs, including ECG, heart rate, breathing rate, skin...

CardioFocus HeartLightâ„¢ Endoscopic Ablation System to be Featured at EHRA EUROPACE 2011

June 22, 2011 3:37 am | by Bio-Medicine.Org | News | Comments

MARLBOROUGH, Mass., June 22, 2011 /- CardioFocus, Inc., developer of the HeartLight™ Endoscopic Ablation System (EAS) for the treatment of atrial fibrillation (AF), announced today that its technology will be the subject of several scientific sessions at the upcoming European Heart...

ERT to Present at the 2011 Wells Fargo Securities Healthcare Conference on June 23, 2011

June 17, 2011 6:32 am | by Bio-Medicine.Org | News | Comments

PHILADELPHIA, June 17, 2011 /- ERT (NASDAQ: ERT ), announced today that Keith Schneck, the Company's Chief Financial Officer, is scheduled to present at the 2011 Wells Fargo Securities Healthcare Conference at 1:30 PM ET on Thursday, June 23, 2011 in Boston. Interested...

Omnicell's OmniRx Automated Medication Dispensing System Receives 2011 Best in KLAS Award

June 16, 2011 11:33 am | by Bio-Medicine.Org | News | Comments

MOUNTAIN VIEW, Calif., June 16, 2011 /- Omnicell, Inc . (NASDAQ: OMCL ), a leading provider of medication and supply management solutions and analytics software for healthcare facilities, today announced the leading research firm, KLAS, has recognized Omnicell OmniRx ® automated...

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading